PROMISE Dept, UOC of Pneumology, University of Palermo, Palermo, Italy.
Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy.
Eur Respir Rev. 2019 Nov 6;28(154). doi: 10.1183/16000617.0030-2019. Print 2019 Dec 31.
Obstructive sleep apnoea (OSA) and obstructive sleep apnoea/hypopnoea syndrome (OSAHS) have long been considered predominantly male-related conditions. The clinical presentation of sleep disordered breathing in females differs from males and can vary with age and physiological status, menopause and pregnancy. Overall, females appear to be more symptomatic, with lower apnoea-hypopnoea index scores compared to males. Furthermore, they appear to have more prolonged partial upper airway obstruction, and may report insomnia as a symptom of OSAHS more frequently. As a consequence of these differences in clinical presentation, females with sleep disordered breathing are often underdiagnosed and undertreated compared to males. This review is aimed at discussing the epidemiology, clinical presentation, pathophysiology and hormonal and metabolic differences in females who present with OSA/OSAHS in comparison to males.
阻塞性睡眠呼吸暂停(OSA)和阻塞性睡眠呼吸暂停低通气综合征(OSAHS)长期以来被认为主要与男性有关。女性睡眠呼吸紊乱的临床表现与男性不同,并且可能随年龄和生理状态、更年期和怀孕而变化。总的来说,女性似乎更有症状,与男性相比,呼吸暂停低通气指数评分较低。此外,她们似乎有更长时间的部分上气道阻塞,并且可能更频繁地报告失眠作为 OSAHS 的症状。由于临床表现的这些差异,与男性相比,患有睡眠呼吸紊乱的女性往往被误诊和治疗不足。本综述旨在讨论与男性相比,出现 OSA/OSAHS 的女性在流行病学、临床表现、病理生理学以及激素和代谢方面的差异。